# Understanding the DEVICE Act of 2021

This bill is about making sure the FDA knows when medical device manufacturers make important changes to their products and how they're supposed to be cleaned. Think of it like requiring car manufacturers to notify regulators whenever they change how a vehicle is designed or maintained.

The bill creates three main reporting requirements for medical device companies. First, manufacturers must tell the FDA before they change how a device is designed or how it should be cleaned and reprocessed. This is important because if a hospital is using surgical instruments or other reusable medical equipment, they need to know if the manufacturer has changed something about how that device should be handled. Second, if a device company sends information to doctors or hospitals in other countries about design changes, safety concerns, or new cleaning procedures, they have to report that communication to the FDA within five days. The idea here is that the FDA shouldn't learn about potential safety issues from foreign countries before learning about them domestically. Third, the bill creates a new category of medical devices called "rapid assessment tests" that are designed to check whether reusable medical equipment has been properly cleaned and sterilized. These tests would be regulated like other medical devices.

The practical effect is that hospitals and healthcare facilities should get better information about their medical equipment, and the FDA will have better oversight of what manufacturers are doing. If a company fails to report these changes, their device can be considered "adulterated" under federal law, which means it can't be legally sold. This is meant to catch safety problems earlier and ensure that when hospitals reuse medical equipment, they're doing it correctly and safely.

DEVICE Act of 2021

Lieu, Ted

Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2021 or the DEVICE Act of 2021 This bill addresses design changes and reprocessing of medical devices. Specifically, medical device manufacturers must notify the Food and Drug Administration (1) before making changes to the design or reprocessing instructions of a device, and (2) no more than five days after widely disseminating to health care providers in a foreign country communications regarding changes to the design or reprocessing instructions of a device or regarding a safety concern about a device. (Reprocessing of medical devices is the process for cleaning and sterilizing or disinfecting devices for reuse.) A device may not be sold if the manufacturer violates these notification requirements.